Christina L. Costantino

Author

Also Known As

C Costantino, C. Costantino, C. L. Costantino, C.L. Costantino, CL Costantino, Christina Costantino, Christina L Costantino, Christina L. Costantino

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Thomas Jefferson University Harvard University Sidney Kimmel Cancer Center Howard Hughes Medical Institute

About

Christina L. Costantino is an author at Massachusetts General Hospital specializing in medicine, surgery, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.1K
2	Cell Biology	3	3	304
3	Arts	1	1	22
4	Engineering	1	1	655
5	Health Sciences	1	1	53

Christina L. Costantino

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Integrating genomic features for non-invasive early lung cancer detection Jacob J. Chabon, Emily G. Hamilton, David M. Kurtz, Nature EngineeringCancer DetectionGenomic FeaturesMedicineMultiple Pulmonary Nodule	2020	655
The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase Christina L. Costantino, Agnieszka K. Witkiewicz, Yuki Kuwano, Cancer Research	2009	181
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival Jonathan R. Brody, Christina L. Costantino, Adam C. Berger, Cell Cycle Cancer ImmunosurveillanceMedicineMelanomaImmune RegulationImmunology	2009	169
Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active Target Agnieszka K. Witkiewicz, Christina L. Costantino, Richard Metz, Journal of the American College of Surgeons	2009	125
Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells Christine L. Hostetter, Lauren A. Licata, Christina L. Costantino, Cancer Biology & Therapy	2008	93
Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma Jonathan R. Brody, Christina L. Costantino, Magdalena Potoczek, Modern Pathology Tp53 Molecular AlterationsPancreatic CancerMedicineAdenosquamous CarcinomaPathology	2009	90
Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening Trial Alexandra L. Potter, Christina L. Costantino, Raiya A. Suliman, The Annals of Thoracic Surgery Surgical OncologyCancer DetectionCancer ScreeningCancer RecurrenceMedicine	2023	53
pp32 (ANP32A) Expression Inhibits Pancreatic Cancer Cell Growth and Induces Gemcitabine Resistance by Disrupting HuR Binding to mRNAs Timothy K. Williams, Christina L. Costantino, Nikolai A. Bildzukewicz, PLoS ONE Chemoprevention StrategyCancer BiologyTumor BiologySignaling PathwayPancreatic Cancer	2010	45
Carinal surgery: A single-institution experience spanning 2 decades Christina L. Costantino, Abraham Geller, Cameron D. Wright, Journal of Thoracic and Cardiovascular Surgery Carinal SurgerySurgerySurgical SpecialtyGeneral SurgeryMedicine	2018	40
Naturally occurring K vitamins inhibit pancreatic cancer cell survival through a caspase‐dependent pathway Shayna L. Showalter, Ziqiu Wang, Christina L. Costantino, Journal of Gastroenterology and Hepatology	2009	33

Page 1